Page last updated: 2024-10-21

3-methylcholanthrene and Cushing Syndrome

3-methylcholanthrene has been researched along with Cushing Syndrome in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, T1
Iwasaki, Y1
Adachi, Y1

Reviews

1 review available for 3-methylcholanthrene and Cushing Syndrome

ArticleYear
[Enzyme induction in the liver--its mechanism and clinical significance].
    Nihon rinsho. Japanese journal of clinical medicine, 1972, Volume: 30, Issue:9

    Topics: Animals; Cushing Syndrome; DNA; Dogs; Drug Synergism; Enzyme Induction; Enzyme Repression; Glucocort

1972